Aster DM Quality Care share price today

Aster DM Quality Care Ltd's share price was ₹719.55 at the close on 4 November 2026. It has been rising for 34 weeks. That is 0.6% above its average price over the last 200 trading days. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 6 weeks running.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Aster DM Quality Care Ltd is in stage 2. The phase helps read everything below.

In the last 52 weeks it traded between ₹555 and ₹870, and at that close it sat 52% of the way up from that low.

Over the last 8.7 years the share price moved +317% while the NIFTY 500 moved +145%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 25 September 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Two changes stood out: revenue up on a year earlier for 10 quarters in a row and highest quarterly revenue in 14 quarters.

1. Revenue up on a year earlier for 10 quarters in a row

   In the June 2026 quarter revenue was ₹1,311 crore, +21.6% on a year earlier.

   Why: Revenue rose because more patients came in and each patient spent more, helped by treating more complex cases and using beds better.

   Next results: check whether patient numbers and revenue per patient keep rising, since management expects at least 5 to 6% more patients and 7 to 8% higher revenue per patient.

   From the earnings call on 5 Aug 2026.

2. Highest quarterly revenue in 14 quarters

   Revenue of ₹1,311 crore in the June 2026 quarter is the highest of the last 14 quarters.

For April to June 2026 (the quarter ended 30 June 2026), Aster DM Quality Care reported revenue of ₹1,311 crore, up 21.6% from ₹1,078 crore a year earlier, and a profit of ₹29.0 crore, down 69.1% from ₹94.0 crore.

Aster DM Quality Care results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Aster DM Quality Care's management discussed these results on a call held on 5 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Aster DM Quality Care closed at ₹719.55 on 4 November 2026, up 3.8% from ₹692.90 a year earlier (7 November 2025) and up 271.4% over five years. Its highest weekly close since March 2018 was ₹869.70 on 7 August 2026.

Aster DM Quality Care share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

460 weekly closes from 1 March 2018 to 4 November 2026.

4 Nov 2026: Aster DM Quality Care closed at ₹719.55, up 5.6% on the week and up 1.5% on the month. 5 Aug 2026: Aster DM Quality Care held its results call for April to June 2026. Management guided: Consolidated operating margin to reach 24-25% between FY28 and FY29.

Earlier

• Results for April to June 2026: Revenue up 21.6% and profit down 69.1% on a year earlier.
• 2 Apr 2026: ex-date for an interim dividend of ₹3 a share, record date 3 Apr 2026.

Aster DM Quality Care paid ₹3 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.42% at the ₹719.55 close on 4 November 2026. The last was an interim dividend of ₹3 a share, ex-date 2 April 2026.

Aster DM Quality Care dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date.

Yes. Aster DM Quality Care Ltd paid out 40% of its profit as dividends in FY26, and it paid a dividend in 4 of its last 13 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 5 August 2026, Aster DM Quality Care's management guided: Consolidated operating margin to reach 24-25% between FY28 and FY29.

“About a year ago, we said that we hoped to bring in 10-15% incremental EBITDA on account of synergies, and we continue to stand by that.”Varun Khanna, on the call for April to June 2026

What management guided

• Merger synergies planned at 10-15% of FY24 operating profit, equivalent to ₹150-200 crore, with significant results during FY27 and annualization next year.
• At least 5-6% organic volume growth and perhaps 7-8% ARPOB growth framed as the operating path to the margin goal.
• Add 4,170 beds over 3-4 years to reach 15,000 beds, with 53% brownfield-led.
• Medical value travel growth expected above 50%.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 5 August 2026.

When Aster DM Quality Care reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Synergy contribution to become visible during FY27; check consumption, revenue, cost, and clinical-talent execution in the next print.

Aster DM Quality Care is on one of our India lists: Small & mid cap stocks.

Aster DM Quality Care Ltd earned ₹29.0 Cr of net profit in the Jun 2026 quarter, −69.1% on the same quarter a year earlier. Full-year FY26 profit was ₹427 Cr. Over 10 years profit has grown 48.8% a year on average. That is 2.2% of the quarter's revenue. The same quarter a year earlier earned ₹94.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

2 of the last 12 reported quarters were loss-making.

For the full year, FY26 profit was ₹427 Cr (−92.1% on the year before).

Why profit moved: revenue changed +21.6% on a year earlier and the margin moved +1.0 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +4.1% and revenue +15.8%. Profit is growing slower than sales: rising costs are taking part of the growth.

Aster DM Quality Care Ltd reported ₹1,311 Cr of revenue in the Jun 2026 quarter, +21.6% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 10 years it has grown −1.2% a year on average. The last full year, FY26, came in at ₹4,643 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹4,876 Cr.

FY26 revenue was ₹4,643 Cr, +12.2% on the year before.

Recent pace: the last four quarters grew +15.8% on average, against −1.2% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +15.7%, against +12.4% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +3.7%, against −73.9% a year (accelerating).

Aster DM Quality Care Ltd's operating margin was 20.0% in the Jun 2026 quarter, 1.0 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 13 years it has been between 6.0% and 19.0%. The latest quarter is above every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +0.8 percentage points on the year while gross margin changed +0.7 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold.

Over the last 3 years, 20% of Aster DM Quality Care Ltd's reported profit came in as cash from its operations, a gap worth watching. In FY26 it brought in ₹656 Cr of operating cash against ₹427 Cr of profit. After ₹713 Cr of spending on assets, free cash was −₹57.0 Cr: it spent more than its operations brought in.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: it has been selling more assets than it buys. The next section shows those figures.

Aster DM Quality Care Ltd's customer, stock and supplier day counts come out in the thousands of days on sales this small (₹4,643 Cr in FY26), so no cash-cycle chart is drawn and this section looks at its spending on assets instead. Over the last 3 years it sold more assets than it bought, by ₹3,936 Cr.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Over the last 3 years, money from selling assets was ₹3,936 Cr more than it spent on new ones. Work still in progress is ₹420 Cr (FY26).

In short: assets are being sold, not built, so this cash is not going into new capacity.

Aster DM Quality Care Ltd's P/E is 173.3×, about the highest it has ever been. Its usual P/E (the middle reading) is 42.3×, over 8.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹6.15.

Why the multiple is where it is: over the past year earnings per share moved −93.0% while the price moved +3.8%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 5 years the price moved +30.0% a year; about −5.6% a year came from earnings growth and about +35.6 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Aster DM Quality Care Ltd's business is getting better. Profit growth hit its low 3 quarters ago at −93.3% and has recovered to +3.7%, with ROCE steady at 9.9%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: a lasting rise from a low is what this page is built to show.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Aster DM Quality Care Ltd earned a ROCE of 12% in FY26. That is up from a low of 1% in FY17. Its return on capital used (ROIC) is 4.2 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses.

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

It comes from a 9.2% net margin and 0.57× asset turnover (sales divided by assets).

Why the return is what it is (FY26): a 9.2% net margin × 0.57× asset turnover × 1.92× leverage (assets divided by equity) ≈ 10.1% on equity. The margin does its share; borrowing is a big part of it.

The key test, return on capital used minus the cost of capital: 7.8% − 12.0% = −4.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.